These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36370997)

  • 21. Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.
    Das S; Filippone SM; Williams DS; Das A; Kukreja RC
    Mol Cell Biochem; 2016 Oct; 421(1-2):89-101. PubMed ID: 27565811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.
    Kang JY; Eggert M; Mouli S; Aljuffali I; Fu X; Nie B; Sheil A; Waddey K; Oldham CD; May SW; Amin R; Arnold RD
    Pharm Res; 2015 Mar; 32(3):852-62. PubMed ID: 25158648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
    Pereira S; Ma G; Na L; Hudoklin S; Kreft ME; Kostevsek N; Al-Jamal WT
    Acta Biomater; 2022 Mar; 140():530-546. PubMed ID: 34954416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy.
    Yu J; Wang Y; Zhou S; Li J; Wang J; Chi D; Wang X; Lin G; He Z; Wang Y
    Acta Pharm Sin B; 2020 Sep; 10(9):1730-1740. PubMed ID: 33088692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.
    Cui N; Wu F; Lu WJ; Bai R; Ke B; Liu T; Li L; Lan F; Cui M
    J Cell Mol Med; 2019 Jul; 23(7):4627-4639. PubMed ID: 31106979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor.
    Mayer LD; Bally MB; Cullis PR; Wilson SL; Emerman JT
    Cancer Lett; 1990 Sep; 53(2-3):183-90. PubMed ID: 2208078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
    Olivieri J; Perna GP; Bocci C; Montevecchi C; Olivieri A; Leoni P; Gini G
    Oncologist; 2017 Apr; 22(4):422-431. PubMed ID: 28275118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q
    Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
    Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
    Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin.
    Abdullah CS; Ray P; Alam S; Kale N; Aishwarya R; Morshed M; Dutta D; Hudziak C; Banerjee SK; Mallik S; Banerjee S; Bhuiyan MS; Quadir M
    Mol Pharm; 2020 Dec; 17(12):4676-4690. PubMed ID: 33151075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R; Mayer LD
    Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells.
    Hu B; Zhen D; Bai M; Xuan T; Wang Y; Liu M; Yu L; Bai D; Fu D; Wei C
    J Ethnopharmacol; 2022 Apr; 288():114936. PubMed ID: 35007682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.
    Krishna R; St-Louis M; Mayer LD
    Int J Cancer; 2000 Jan; 85(1):131-41. PubMed ID: 10585596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity.
    Shi C; Wu H; Xu K; Cai T; Qin K; Wu L; Cai B
    Int J Nanomedicine; 2020; 15():1101-1115. PubMed ID: 32110010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells.
    Porfire A; Tomuta I; Muntean D; Luca L; Licarete E; Alupei MC; Achim M; Vlase L; Banciu M
    J Liposome Res; 2015; 25(4):261-9. PubMed ID: 25487170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.
    Barbălată CI; Porfire AS; Sesarman A; Rauca VF; Banciu M; Muntean D; Știufiuc R; Moldovan A; Moldovan C; Tomuță I
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced antitumor efficacy and attenuated cardiotoxicity of doxorubicin in combination with lycopene liposomes.
    Zhu J; Hu Q; Shen S
    J Liposome Res; 2020 Mar; 30(1):37-44. PubMed ID: 30741056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
    Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
    Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.